Curdy C - Search Results

1

Post-iontophoresis recovery of human skin impedance in vivo.

Curdy C, Kalia YN, Guy RH. Curdy C, et al. Eur J Pharm Biopharm. 2002 Jan;53(1):15-21. doi: 10.1016/s0939-6411(01)00216-8. Eur J Pharm Biopharm. 2002. PMID: 11777748

2

Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo.

Curdy C, Naik A, Kalia YN, Alberti I, Guy RH. Curdy C, et al. Int J Pharm. 2004 Mar 1;271(1-2):251-6. doi: 10.1016/j.ijpharm.2003.11.016. Int J Pharm. 2004. PMID: 15129992

3

Non-invasive assessment of the effects of iontophoresis on human skin in-vivo.

Curdy C, Kalia YN, Guy RH. Curdy C, et al. J Pharm Pharmacol. 2001 Jun;53(6):769-77. doi: 10.1211/0022357011776117. J Pharm Pharmacol. 2001. PMID: 11428652 Review.

4

Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion.

Curdy C, Kalia YN, Naik A, Guy RH. Curdy C, et al. J Control Release. 2001 Sep 11;76(1-2):73-9. doi: 10.1016/s0168-3659(01)00418-7. J Control Release. 2001. PMID: 11532314

5

Recovery of human skin impedance in vivo after iontophoresis: effect of metal ions.

Curdy C, Kalia YN, Falson-Rieg F, Guy RH. Curdy C, et al. AAPS PharmSci. 2000;2(3):E23. doi: 10.1208/ps020323. AAPS PharmSci. 2000. PMID: 11741239 Free PMC article.

6

Normalization of stratum corneum barrier function and transepidermal water loss in vivo.

Kalia YN, Alberti I, Sekkat N, Curdy C, Naik A, Guy RH. Kalia YN, et al. Among authors: curdy c. Pharm Res. 2000 Sep;17(9):1148-50. doi: 10.1023/a:1026474200575. Pharm Res. 2000. PMID: 11087050 No abstract available.

7

Poly(ethylene carbonate) as a surface-eroding biomaterial for in situ forming parenteral drug delivery systems: a feasibility study.

Liu Y, Kemmer A, Keim K, Curdy C, Petersen H, Kissel T. Liu Y, et al. Among authors: curdy c. Eur J Pharm Biopharm. 2010 Oct;76(2):222-9. doi: 10.1016/j.ejpb.2010.07.009. Epub 2010 Jul 19. Eur J Pharm Biopharm. 2010. PMID: 20650316

8

In situ forming parenteral depot systems based on poly(ethylene carbonate): effect of polymer molecular weight on model protein release.

Chu D, Curdy C, Riebesehl B, Beck-Broichsitter M, Kissel T. Chu D, et al. Among authors: curdy c. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1245-9. doi: 10.1016/j.ejpb.2013.05.020. Epub 2013 Jun 19. Eur J Pharm Biopharm. 2013. PMID: 23791717

9

Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery.

Supper S, Anton N, Boisclair J, Seidel N, Riemenschnitter M, Curdy C, Vandamme T. Supper S, et al. Among authors: curdy c. Eur J Pharm Biopharm. 2014 Oct;88(2):361-73. doi: 10.1016/j.ejpb.2014.05.015. Epub 2014 May 22. Eur J Pharm Biopharm. 2014. PMID: 24859306

10

Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with "stealth" potential.

Bege N, Renette T, Jansch M, Reul R, Merkel O, Petersen H, Curdy C, Müller RH, Kissel T. Bege N, et al. Among authors: curdy c. Macromol Biosci. 2011 Jul 7;11(7):897-904. doi: 10.1002/mabi.201000496. Epub 2011 Apr 5. Macromol Biosci. 2011. PMID: 21472988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters